EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 51 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | -100.0% | 938 | -11.8% | 0.00% | – |
Q2 2023 | $1,000 | -66.7% | 1,063 | -65.6% | 0.00% | – |
Q1 2023 | $3,000 | -62.5% | 3,093 | -55.1% | 0.00% | – |
Q4 2022 | $8,000 | -50.0% | 6,891 | +234.2% | 0.00% | – |
Q3 2022 | $16,000 | +128.6% | 2,062 | +83.9% | 0.00% | – |
Q2 2022 | $7,000 | -68.2% | 1,121 | -58.7% | 0.00% | – |
Q1 2022 | $22,000 | -40.5% | 2,717 | -61.7% | 0.00% | – |
Q4 2021 | $37,000 | +19.4% | 7,085 | +51.7% | 0.00% | – |
Q3 2021 | $31,000 | +24.0% | 4,669 | +58.7% | 0.00% | – |
Q2 2021 | $25,000 | -13.8% | 2,942 | -10.2% | 0.00% | – |
Q1 2021 | $29,000 | -14.7% | 3,276 | +16.7% | 0.00% | – |
Q4 2020 | $34,000 | +466.7% | 2,807 | +274.3% | 0.00% | – |
Q3 2020 | $6,000 | -14.3% | 750 | -0.9% | 0.00% | – |
Q2 2020 | $7,000 | +40.0% | 757 | +12.8% | 0.00% | – |
Q1 2020 | $5,000 | -86.5% | 671 | -73.5% | 0.00% | – |
Q4 2019 | $37,000 | +825.0% | 2,532 | +655.8% | 0.00% | – |
Q2 2019 | $4,000 | – | 335 | +2133.3% | 0.00% | – |
Q3 2018 | $0 | – | 15 | +1400.0% | 0.00% | – |
Q2 2018 | $0 | -100.0% | 1 | -99.3% | 0.00% | – |
Q1 2017 | $2,000 | -50.0% | 152 | -52.6% | 0.00% | – |
Q4 2016 | $4,000 | – | 321 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
P.A.W. CAPITAL CORP | 540,000 | $4,482,000 | 4.68% |
Knoll Capital Management, LLC | 694,232 | $5,762,000 | 3.62% |
Telemetry Investments, L.L.C. | 213,000 | $1,768,000 | 2.79% |
ACT CAPITAL MANAGEMENT, LLC | 250,000 | $2,075,000 | 2.20% |
VR Adviser, LLC | 1,469,767 | $12,199,000 | 1.98% |
INTERWEST VENTURE MANAGEMENT CO | 560,990 | $4,656,000 | 1.78% |
683 Capital Management, LLC | 3,375,000 | $28,013,000 | 1.50% |
Trellus Management Company, LLC | 300,000 | $2,490,000 | 1.45% |
Altium Capital Management LP | 440,000 | $3,652,000 | 1.22% |
CAXTON CORP | 116,884 | $970,000 | 1.21% |